These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3359222)

  • 1. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; Saleh J; DeLaPaz R; Kunis D; Zarnegar SR
    Brain Res; 1989 Sep; 497(2):382-6. PubMed ID: 2684345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anesthetized rat.
    Tortella FC; Martin DA; Allot CP; Steel JA; Blackburn TP; Loveday BE; Russell NJ
    Brain Res; 1989 Mar; 482(1):179-83. PubMed ID: 2706475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of dextromethorphan on c-fos protein expression during focal cerebral ischemia in rats.
    Bao WL; Lu SD; Cheng JS; Zhang AZ
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):418-20. PubMed ID: 9863163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia.
    Lo EH; Steinberg GK
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):803-9. PubMed ID: 1874811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity.
    Choi DW
    Brain Res; 1987 Feb; 403(2):333-6. PubMed ID: 2881608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia.
    Prince DA; Feeser HR
    Neurosci Lett; 1988 Mar; 85(3):291-6. PubMed ID: 3362419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.
    Ozyurt E; Graham DI; Woodruff GN; McCulloch J
    J Cereb Blood Flow Metab; 1988 Feb; 8(1):138-43. PubMed ID: 2892846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan protects retina against ischemic injury in vivo.
    Yoon YH; Marmor MF
    Arch Ophthalmol; 1989 Mar; 107(3):409-11. PubMed ID: 2923566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.
    Goldberg MP; Pham PC; Choi DW
    Neurosci Lett; 1987 Sep; 80(1):11-5. PubMed ID: 3658226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC; Britton P; Williams A; Lu XC; Newman AH
    J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.